We are monitoring the impact of COVID-19 on North America Biopharmaceutical Contract Manufacturing Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 7600
Share on
Share on

North America Biopharmaceutical Contract Manufacturing Market Research Report - Segmented By Product Type, Therapeutic Area, Application & Country (U.S, Canada & Rest of North America) - Industry Analysis, Share, Size, Trends, Growth, & Forecasts (2021 to 2026)

Pulished: April, 2021
ID: 7600
Pages: 145

North America Biopharmaceutical Contract Manufacturing Market Size & Growth (2021 to 2026):

As per the research report, the size of the North America Biopharmaceutical contract manufacturing market is valued at USD 1.72 billion in 2021. It is expected to rise at a CAGR of 10% and expand to USD 2.76 billion by 2026.

A contract manufacturing organization is a company that provides comprehensive services to other biopharmaceutical firms on a contract basis, ranging from drug development to medicine production. It enables large biopharmaceutical companies to outsource certain aspects of their operations, concentrating on medicine development and marketing. The biotechnology sector continues to outsource to contract manufacturing businesses to meet its fill-and-finish needs and reduce risk.

Also, due to a lack of in-house capacity, several small biotechnology organizations outsource their fill and finish manufacturing needs, which helps organizations retain capital expenditures and lowers the risk involved in the business. Furthermore, these firms' outsourcing strategy is complicated and changes based on the product life cycle, product phase, volume, and profitability. 

Even with the increase in the demand for outsourcing, notably in cell culture technologies and novel modalities, More than 235 businesses now provide contract manufacturing services for biopharmaceuticals with a wide range of handling biologics. Proteins/peptides, antibodies, and vaccines are among the most common services offered by contract manufacturing organizations. Furthermore, mammalian cell-based production is more common than microbial expression methods. A contract manufacturing organization is a firm that provides complete services from drug research to medication manufacture to other biopharmaceutical companies on a contract basis. 

However, the prominent drivers driving the antibodies segment are the increase in the investments of the technological improvements in monoclonal antibody treatment and increased research & development efforts. As monoclonal antibody treatment is a kind of immunotherapy in which antibodies are attached to specific cells or proteins, causing the patient's immune system to destroy them. These medicinal substances are used to treat various types of malignancy. The most common type of biologic is monoclonal antibodies, and it has been approved for nearly all types of medicines. 

However, an increase in the high costs of transportation costs with the rise in the competition in the market is likely to affect market growth due to strict rules and regulations for introducing the new product.

This research report on the North America Biopharmaceutical Contract Manufacturing Market has been segmented and sub-segmented into the following categories:

By Product Type:

  • Insulin
  • Monoclonal Antibodies
  • Growth Factors
  • Interferons
  • Recombinant Proteins
  • Vaccines
  • Others

By Therapeutic Area:

  • Infectious Disease
  • Cardiovascular Disease
  • Oncology
  • Metabolic Disease
  • Respiratory Disorder
  • Autoimmune Disease
  • Neurology
  • Ophthalmology
  • Others

By Application:

  • Commercial
  • Clinical

By Country:

  • U.S
  • Canada
  • Rest of North America

The North American market is geographically the largest and dominates the global North America Biopharmaceutical Contract Manufacturing Market and is estimated to account for predominant growth during the forecast period. Increase in the biopharmaceuticals contract manufacturing markets, the rise in the outsourcing volume by bio- pharmaceuticals industries, and availability of advanced technology in the region.

Moreover, Mergers, acquisitions, and joint ventures are typical industry strategies because they enable contract manufacturing organizations to provide integrated bioprocessing services, making them a more dependable alternative for a quick product launch for commercial usage. Furthermore, the growing emphasis on superior biopharmaceutical products, biosimilar, and biopharmaceutical-based research and development activities accounted for a large percentage of total research and development activities in various sectors, fueling the overall regional market growth to a large extent.

The U.S Biopharmaceutical Contract Manufacturing Market dominates the market by big pharma companies owing to the increase in the vast number of biopharmaceutical firms with substantial production capabilities and the high consumption of biologics in this area. Also, with the rise in the investment and initiatives in research and development with the increase in the competition in the market for maintaining the position.

KEY MARKET PLAYERS

Companies playing a dominant role in the North America Biopharmaceutical contract manufacturing market profiled in this report are Lonza Group AG, Baxter Biopharma Solutions, Samsung Biologics Co., Ltd., Fujifilm Diosynth Biotechnologies, Boehringer Ingelheim GmbH, Patheon N.V., Rentschler Biotechnologie GmbH, Biomeva GmbH, Probiogen AG, Cytovance Biologics, Inc., KBI Biopharma, Inc., WuXi Biologics, Abzena Plc, Vetter Pharma International GmbH, Sandoz International GmbH, Catalent, Inc., AbbVie Contract Manufacturing (An AbbVie Company), Ajinomoto Althea Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product Type                             

                                5.1.1 Introduction           

                                5.1.2 Insulin       

                                5.1.3 Monoclonal Antibodies     

                                5.1.4 Growth Factors     

                                5.1.5 Interferons             

                                5.1.6 Recombinant Protiens       

                                5.1.7 Vaccines   

                                5.1.8 Others      

                                5.1.9  Y-o-Y Growth Analysis, By Product Type   

                                5.1.10  Market Attractiveness Analysis, By Product Type               

                                5.1.11  Market Share Analysis, By Product Type

                5.2 Therapeutic Area                     

                                5.2.1 Introduction           

                                5.2.2 Infectious Disease               

                                5.2.3Cardiovascular Disease       

                                5.2.4 Oncology 

                                5.2.5 Metabolic Disease               

                                5.2.6 Respiratory Disorder           

                                5.2.7 Autoimmune Disease         

                                5.2.8 Neurology               

                                5.2.9 Ophthalmology     

                                5.2.10 Others    

                                5.2.11 Y-o-Y Growth Analysis, By Therapeutic Area          

                                5.2.12 Market Attractiveness Analysis, By Therapeutic Area        

                                5.2.13 Market Share Analysis, By Therapeutic Area          

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Clinical       

                                5.3.3 Commercial            

                                5.3.4 Y-o-Y Growth Analysis, By Application         

                                5.3.5 Market Attractiveness Analysis, By Application       

                                5.3.6 Market Share Analysis, By Application        

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product Type

                                                6.1.3.3 By Therapeutic Area

                                                6.1.3.4 By Application

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product Type

                                                6.1.4.3 By Therapeutic Area

                                                6.1.4.4 By Application

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product Type

                                                6.1.5.3 By Therapeutic Area

                                                6.1.5.4 By Application

                6.2 United States                            

                6.3 Canada                         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Patheon N.V.                             

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2Rentschler Biotechnologie GmbH                      

                 8.3 AbbVie Contract Manufacturing (An AbbVie Company)                        

                8.4 Biomeva GmbH                        

                8.5 Boehringer Ingelheim GmbH                              

                8.6 WuXi Biologics                           

                 8.7 Abzena Plc                 

                8.8 Lonza Group AG                       

                8.9 Samsung Biologics Co.                            

                8.10 Ajinomoto Althea, Inc.                        

                8.11 Fujifilm Diosynth Biotechnologies                  

                8.12 Probiogen AG                         

                8.13 Sandoz International GmbH                              

                8.14 KBI Biopharma, Inc.                              

                8.15 Baxter Biopharma Solutions                              

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures  

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Product Type, by  Therapeutic Area along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Bio Pharmaceutical Contract Manufacturing Market By Product Type , From 2021 to 2026 ( USD Billion )
  2. North America Insulin Market By Region, From 2021 to 2026 ( USD Billion )
  3. North America  Monoclonal Antibodies Market By Region, From 2021 to 2026 ( USD Billion )
  4. North America  Growth Factors, Market By Region, From 2021 to 2026 ( USD Billion )
  5. North America  Interferons Market By Region, From 2021 to 2026 ( USD Billion )
  6. North America  Recombinant Proteins Market By Region, From 2021 to 2026 ( USD Billion )
  7. North America Vaccines Market By Region, From 2021 to 2026 ( USD Billion )
  8. North America  Others Market By Region, From 2021 to 2026 ( USD Billion )
  9. North America Bio Pharmaceutical Contract Manufacturing Market By Therapeutic Area, From 2021 to 2026 ( USD Billion )
  10. North America Infectious Disease Market By Region, From 2021 to 2026 ( USD Billion )
  11. North America  Cardiovascular Disease Market By Region, From 2021 to 2026 ( USD Billion )
  12. North America Oncology Market By Region, From 2021 to 2026 ( USD Billion )
  13. North America  Metabolic Disease Market By Region, From 2021 to 2026 ( USD Billion )
  14. North America  Respiratory Disorder Market By Region, From 2021 to 2026 ( USD Billion )
  15. North America  Autoimmune Disease Market By Region, From 2021 to 2026 ( USD Billion )
  16. North America  Neurology Market By Region, From 2021 to 2026 ( USD Billion )
  17. North America  Ophthalmology Market By Region, From 2021 to 2026 ( USD Billion )
  18. North America  Others Market By Region, From 2021 to 2026 ( USD Billion )
  19. North America Bio Pharmaceutical Contract Manufacturing Market By Application, From 2021 to 2026 ( USD Billion )
  20. North America Commercial  Market By Region, From 2021 to 2026 ( USD Billion )
  21. North America  Clinical Market By Region, From 2021 to 2026 ( USD Billion )
  22. United States Bio Pharmaceutical Contract Manufacturing Market By Product Type , From 2021 to 2026 ( USD Billion )
  23. United States Bio Pharmaceutical Contract Manufacturing Market By Therapeutic Area, From 2021 to 2026 ( USD Billion )
  24. United States Bio Pharmaceutical Contract Manufacturing Market By Application, From 2021 to 2026 ( USD Billion )
  25. Canada Bio Pharmaceutical Contract Manufacturing Market By Product Type , From 2021 to 2026 ( USD Billion )
  26. Canada Bio Pharmaceutical Contract Manufacturing Market By Therapeutic Area, From 2021 to 2026 ( USD Billion )
  27. Canada Bio Pharmaceutical Contract Manufacturing Market By Application, From 2021 to 2026 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample